ITMI20042353A1 - PEPTIDES FOR DRUG VEHICLES - Google Patents

PEPTIDES FOR DRUG VEHICLES

Info

Publication number
ITMI20042353A1
ITMI20042353A1 IT002353A ITMI20042353A ITMI20042353A1 IT MI20042353 A1 ITMI20042353 A1 IT MI20042353A1 IT 002353 A IT002353 A IT 002353A IT MI20042353 A ITMI20042353 A IT MI20042353A IT MI20042353 A1 ITMI20042353 A1 IT MI20042353A1
Authority
IT
Italy
Prior art keywords
peptides
drug vehicles
drug
vehicles
Prior art date
Application number
IT002353A
Other languages
Italian (it)
Inventor
Luca Costantino
Flavio Forni
Maria Angela Vandelli
Original Assignee
Uni Degli Studi Di Modena E Re
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Degli Studi Di Modena E Re filed Critical Uni Degli Studi Di Modena E Re
Priority to IT002353A priority Critical patent/ITMI20042353A1/en
Publication of ITMI20042353A1 publication Critical patent/ITMI20042353A1/en
Priority to EP05817909A priority patent/EP1819723A2/en
Priority to PCT/EP2005/012554 priority patent/WO2006061101A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IT002353A 2004-12-10 2004-12-10 PEPTIDES FOR DRUG VEHICLES ITMI20042353A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT002353A ITMI20042353A1 (en) 2004-12-10 2004-12-10 PEPTIDES FOR DRUG VEHICLES
EP05817909A EP1819723A2 (en) 2004-12-10 2005-11-24 Drug delivery peptides for crossing blood-brain barrier
PCT/EP2005/012554 WO2006061101A2 (en) 2004-12-10 2005-11-24 Drug delivery peptides for crossing blood-brain barrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002353A ITMI20042353A1 (en) 2004-12-10 2004-12-10 PEPTIDES FOR DRUG VEHICLES

Publications (1)

Publication Number Publication Date
ITMI20042353A1 true ITMI20042353A1 (en) 2005-03-10

Family

ID=36578268

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002353A ITMI20042353A1 (en) 2004-12-10 2004-12-10 PEPTIDES FOR DRUG VEHICLES

Country Status (3)

Country Link
EP (1) EP1819723A2 (en)
IT (1) ITMI20042353A1 (en)
WO (1) WO2006061101A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2010027108A1 (en) * 2008-09-08 2012-02-02 国立大学法人東京工業大学 Fluorescent sugar derivative compound and sensor using the same
EP2488210A4 (en) 2009-10-12 2014-04-30 Smith Holdings Llc Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
EP2501372A4 (en) 2009-11-19 2013-04-10 Signpath Pharma Inc Intravenous infusion of curcumin and a calcium channel blocker
US9393198B2 (en) * 2010-03-22 2016-07-19 Signpath Pharma Inc. Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders
US10238602B2 (en) 2011-06-03 2019-03-26 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
US10349884B2 (en) 2011-06-03 2019-07-16 Sighpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
US10449193B2 (en) 2011-06-03 2019-10-22 Signpath Pharma Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
US10117881B2 (en) 2011-06-03 2018-11-06 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
US12004868B2 (en) 2011-06-03 2024-06-11 Signpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
US8753674B2 (en) 2011-06-03 2014-06-17 Signpath Pharma Inc. Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
US9138411B2 (en) 2012-08-31 2015-09-22 University Of North Texas Health Science Center At Fort Worth Curcumin-ER, a liposomal-PLGA sustained release nanocurcumin for minimizing QT prolongation for cancer therapy
EP3082768B1 (en) 2013-12-18 2023-02-22 Signpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
KR102603673B1 (en) 2016-04-27 2023-11-17 사인패스 파마 인코포레이티드 Prevention of drug-induced atrio-ventricular block

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10121982B4 (en) * 2001-05-05 2008-01-24 Lts Lohmann Therapie-Systeme Ag Nanoparticles of protein with coupled apolipoprotein E to overcome the blood-brain barrier and process for their preparation

Also Published As

Publication number Publication date
EP1819723A2 (en) 2007-08-22
WO2006061101A3 (en) 2006-09-14
WO2006061101A2 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
DE602005015424D1 (en) VEHICLE OPERATION SUPPORT SYSTEM
DK1891962T3 (en) GLUTATHION-BASED DELIVERY SYSTEM
DE502004004673D1 (en) VEHICLE SYSTEM
DE602004020862D1 (en) airbag system
ITMO20050343A1 (en) SUPPORT FOR MEDICATION
DK1957073T3 (en) PHARMACEUTICAL
DE602005000630D1 (en) airbag system
ITUD20050171A1 (en) VEHICLE PROJECTOR
DK1757293T3 (en) BH4-RESPONSIVE HYPERPHENYLALANINARY MEDICINES
DE602004004745D1 (en) car system
DK1817475T3 (en) HYBRID STIGROSE SYSTEM
ITMI20042353A1 (en) PEPTIDES FOR DRUG VEHICLES
DK1968623T3 (en) Bacteriocin-inducible peptides
DE602005001938D1 (en) vehicle
DE502005004949D1 (en) RESTRAINT SYSTEM
DK1769359T3 (en) Publication data-verification system
DE602005000950D1 (en) vehicle
NO20045614D0 (en) booster
DE602006008718D1 (en) airbag system
ITMO20040147A1 (en) RAMP FOR VEHICLES
ITMO20050297A1 (en) SUPPORT SYSTEM
ITTO20040319A1 (en) VEHICLE POST
FI6455U1 (en) Virtual-window system
ITMI20041593A1 (en) INTERFACE SUPPORT FOR TRANSPORT VEHICLES
ITUD20040067A1 (en) COMBINED BRAKING SYSTEM FOR VEHICLES